Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics

Author:

Martin RebeccaORCID,Maleche Allan,Gay JillORCID,Fatima Haram

Abstract

COVID-19, which killed more than 6 million people, will not be the last pandemic. Vaccines are key to preventing and ending pandemics. Therefore, it is critical to move now, before the next pandemic, towards global vaccine equity with shared goals, intermediate steps and long-term advocacy goals. Scientific integrity, ethical development, transparency, accountability and communication are critical. Countries can draw on lessons learnt from their response to the HIV pandemics, which has been at the vanguard of ensuring equitable access to rights-based services, to create shared goals and engage communities to increase access to and delivery of safe, quality vaccines. Access can be increased by: fostering the spread of mRNA intellectual property (IP) rights, with mRNA vaccine manufacturing on more continents; creating price transparency for vaccines; creating easily understandable, accessible and transparent data on vaccines; creating demand for a new international legal framework that allows IP rights to be waived quickly once a global pandemic is identified; and drawing on scientific expertise from around the world. Delivery can be improved by: creating strong public health systems that can deliver vaccines through the lifespan; creating or strengthening national regulatory agencies and independent national scientific advisory committees for vaccines; disseminating information from reliable, transparent national and subnational surveillance systems; improving global understanding that as more scientific data become available, this may result in changes to public health guidance; prioritising access to vaccines based on scientific criteria during an epidemic; and developing strategies to vaccinate those at highest risk with available vaccines.

Publisher

BMJ

Reference86 articles.

1. Johns Hopkins Coronavirus Resource Center . Johns Hopkins University and medicine [Internet]. 2023. Available: https://coronavirus.jhu.edu/

2. Inequities in access to diagnostics threatens global public health security;Fischer;Lancet Infect Dis,2022

3. National Academies of Sciences and . Toward a post-pandemic world: lessons from COVID-19 for now and the future. Ashby E , Biffl C , Snair M , eds. Proceedings of a Workshop [Internet]; Washington, DC: The National Academies Press, 2022 Available: https://nap.nationalacademies.org/catalog/26556/toward-a-post-pandemic-world-lessons-from-covid-19-for

4. Venkatesan P . Do vaccines protect from long COVID? Lancet Respir Med 2022;10. doi:10.1016/S2213-2600(22)00020-0

5. Ahmad FB , Anderson RN , Cisewski JA , et al . Vital Statistics rapid release. 2020. Available: https://www.cdc.gov/nchs/products/index.htm

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3